Luminor Medical Technologies Inc. (LMT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,551,000 | 3,673,000 | 2,440,000 | 2,547,000 | 2,430,000 |
| Receivables | 16,010,000 | 16,435,000 | 15,772,000 | 14,823,000 | 14,817,000 |
| Inventories | 3,312,000 | 3,498,000 | 3,471,000 | 3,088,000 | 3,113,000 |
| Other current assets | 449,000 | 481,000 | 461,000 | 533,000 | 600,000 |
| TOTAL | $23,322,000 | $24,087,000 | $22,144,000 | $20,991,000 | $20,960,000 |
| Non-Current Assets | |||||
| PPE Net | 8,046,000 | 7,966,000 | 7,938,000 | 7,975,000 | 7,629,000 |
| Intangibles | 13,056,000 | 13,131,000 | 13,173,000 | 13,239,000 | 13,285,000 |
| Other Non-Current Assets | 12,242,000 | 11,794,000 | 11,367,000 | 10,675,000 | 10,156,000 |
| TOTAL | $33,344,000 | $32,891,000 | $32,478,000 | $31,889,000 | $31,070,000 |
| Total Assets | $56,666,000 | $56,978,000 | $54,622,000 | $52,880,000 | $52,030,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 168,000 | 283,000 | 115,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,817,000 | 3,466,000 | 3,271,000 | 2,117,000 | 2,622,000 |
| Accrued Expenses | 3,139,000 | 2,896,000 | 2,634,000 | 3,075,000 | 3,151,000 |
| Other current liabilities | 2,133,000 | 2,875,000 | 2,626,000 | 2,207,000 | 2,515,000 |
| TOTAL | $17,193,000 | $17,704,000 | $16,982,000 | $15,887,000 | $16,347,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,221,000 | 17,262,000 | 15,485,000 | 15,429,000 | 11,480,000 |
| Deferred Revenues | 7,936,000 | 8,184,000 | 8,336,000 | 8,488,000 | 8,059,000 |
| Other Non-Current Liabilities | 12,978,000 | 12,772,000 | 12,509,000 | 12,298,000 | 12,237,000 |
| TOTAL | $30,199,000 | $30,034,000 | $27,994,000 | $27,727,000 | $23,717,000 |
| Total Liabilities | $47,392,000 | $47,738,000 | $44,976,000 | $43,614,000 | $40,064,000 |
| Shareholders' Equity | |||||
| Common Shares | 247,000 | 251,000 | 254,000 | 254,000 | 261,000 |
| Retained earnings | 17,066,000 | 17,068,000 | 17,478,000 | 16,943,000 | 19,839,000 |
| Other shareholders' equity | -8,146,000 | -8,079,000 | -8,086,000 | -8,023,000 | -8,134,000 |
| TOTAL | $9,274,000 | $9,240,000 | $9,646,000 | $9,266,000 | $11,966,000 |
| Total Liabilities And Equity | $56,666,000 | $56,978,000 | $54,622,000 | $52,880,000 | $52,030,000 |